Literature DB >> 9632348

Spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists.

L Yang1, L Guo, A Pasternak, R Mosley, S Rohrer, E Birzin, F Foor, K Cheng, J Schaeffer, A A Patchett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9632348     DOI： 10.1021/jm980194h

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  9 in total

Review 1.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

2.  Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality.

Authors:  Thomas D Prévôt; François Gastambide; Cécile Viollet; Nadia Henkous; Guillaume Martel; Jacques Epelbaum; Daniel Béracochéa; Jean-Louis Guillou
Journal:  Neuropsychopharmacology       Date:  2016-12-16       Impact factor: 7.853

3.  Somatostatin depresses the excitability of subicular bursting cells: Roles of inward rectifier K+ channels, KCNQ channels and Epac.

Authors:  Binqi Hu; Nicholas I Cilz; Saobo Lei
Journal:  Hippocampus       Date:  2017-06-05       Impact factor: 3.899

4.  Molecular basis for the selective G protein signaling of somatostatin receptors.

Authors:  Sijia Chen; Xiao Teng; Sanduo Zheng
Journal:  Nat Chem Biol       Date:  2022-09-22       Impact factor: 16.174

5.  Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2.

Authors:  L Yang; S C Berk; S P Rohrer; R T Mosley; L Guo; D J Underwood; B H Arison; E T Birzin; E C Hayes; S W Mitra; R M Parmar; K Cheng; T J Wu; B S Butler; F Foor; A Pasternak; Y Pan; M Silva; R M Freidinger; R G Smith; K Chapman; J M Schaeffer; A A Patchett
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

6.  Molecular shape and medicinal chemistry: a perspective.

Authors:  Anthony Nicholls; Georgia B McGaughey; Robert P Sheridan; Andrew C Good; Gregory Warren; Magali Mathieu; Steven W Muchmore; Scott P Brown; J Andrew Grant; James A Haigh; Neysa Nevins; Ajay N Jain; Brian Kelley
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

7.  Agonist-biased trafficking of somatostatin receptor 2A in enteric neurons.

Authors:  Peishen Zhao; Meritxell Canals; Jane E Murphy; Diana Klingler; Emily M Eriksson; Juan-Carlos Pelayo; Markus Hardt; Nigel W Bunnett; Daniel P Poole
Journal:  J Biol Chem       Date:  2013-08-02       Impact factor: 5.157

Review 8.  Somatostatin-dopamine ligands in the treatment of pituitary adenomas.

Authors:  Alexandru Saveanu; Philippe Jaquet
Journal:  Rev Endocr Metab Disord       Date:  2008-07-24       Impact factor: 6.514

9.  SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells.

Authors:  Balrik Kailey; Martijn van de Bunt; Stephen Cheley; Paul R Johnson; Patrick E MacDonald; Anna L Gloyn; Patrik Rorsman; Matthias Braun
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-28       Impact factor: 4.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.